亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

噻康唑 65899-73-2原料藥

 
 
單價(jià) 22.00 / 公斤對(duì)比
銷量 暫無
發(fā)貨 湖北武漢市付款后24小時(shí)內(nèi)
庫存 900公斤起訂1公斤
品牌 鑫佳靈
型號(hào) 65899-73-2
規(guī)格 原料藥
過期 長期有效
更新 2012-12-03 22:39
 

武漢鑫佳靈醫(yī)藥化學(xué)有限公司

企業(yè)會(huì)員第14年
資料未認(rèn)證
保證金未繳納
詳細(xì)說明

噻康唑 65899-73-2原料藥
    中文同義詞: 噻康唑;1-[2-[(2-氯-3-噻吩基)]-2-(2,4-苯基基)]乙基咪唑;嗎硫酸鹽
    英文名稱: Vagistat
    英文同義詞: (+-)-1-(2,4-dichloro-beta-((2-chloro-3-ethenyl)oxy)phenethyl)imidazole;1-(2-((2-chloro-3-thienyl)methoxy)-2-(2,4-dichlorophenyl)ethyl)-1h-imidazol;vagistat;TIOCONAZOLE;1-[2-[(2-chlorothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)-ethyl]imidazole;TIOCONAZOLE ASSAY STANDARD BP(CRM STANDARD);TIOCONAZOLE BP STANDARD(CRM STANDARD);TIOCONAZOLE FOR SYSTEM SUITABILITY EPY(CRM STANDARD)
    CAS號(hào): 65899-73-2
    分子式: C16H13Cl3N2OS
    分子量: 387.71
    EINECS號(hào): 265-973-8
    Mol文件: 65899-73-2.mol
武漢鑫佳靈生物醫(yī)藥有限公司 027-59848789/15972030797
武漢鑫佳靈生物醫(yī)藥有限公司 027-59222660/13720259278
武漢鑫佳靈生物醫(yī)藥有限公司 027-59222350/15972030793
舉報(bào)收藏 0評(píng)論 0
更多>本企業(yè)其它產(chǎn)品
硝酸益康唑27220-47-9原料藥 鹽酸萘甲唑啉550-99-2原料藥 維生素E煙酸酯/VE煙酸酯16676-75-8原料藥 鹽酸東布曲明265-5862-2354原料藥 鹽酸美金剛 41100-52-1原料藥 愈創(chuàng)木酚磺酸鉀1321-14-8原料藥 4-乙基愈創(chuàng)木酚  2785-89-9原料藥
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |